Stay up-to-date with the latest developments in securities law through access to both news and all statutes and regulations. Find relevant corporate filings through a searchable EDGAR database. And...
The Securities and Exchange Commission brought or settled insider training complaints this week involving former vice presidents at Synaptics Inc. and Sequenom Inc. and a scientist at Laboratory Corp. of America. In settling, defendants neither admit nor deny wrongdoing.
Fred Tinker, former vice president of finance for Synaptics Inc., allegedly used his wife’s brokerage account to trade just before acquisition talks became public. Tinker learned a Chinese investment firm was interested in purchasing Synaptics, a touch-pad technology company. He then bought 10,000 Synaptics shares using his wife’s account, selling the shares a few months after Bloomberg reported on the acquisition talks in September 2015.
Tinker, based in Los Altos, Calif., saw an “unrealized gain” of about $90,000 when the stock price increased upon news of the acquisition talks. He settled with the SEC on July 31 for just under $187,000, including an almost $90,000 fine.
Robert Lozuk, until October 2016 a senior vice president of commercial operations at prenatal testing firm Sequenom Inc., allegedly tipped a childhood friend about an upcoming merger. Lozuk told his friend, John Kollus, about Laboratory Corp. of America Holding’s bid for Sequenom at a social event a week before the companies publicly announced the merger. Kollus made nearly $27,000 in profit on the tipped trades, the SEC said.
Lozuk, who lives in Carlsbad, Calif., settled with the SEC on Aug. 1 for about $27,000. Kollus, a sales manager at a media and financial information company, entered a deferred prosecution agreement with the SEC in June. Lozuk also agreed to a five-year bar on serving as an officer or director of a public company.
Laboratory Corp. of America Holding scientist Anup Madan allegedly made over $14,000 on insider trades surrounding the company’s acquisition of Sequenom. Madan, a scientist at a LabCorp genome facility, learned about the merger when his company sent him to Sequenom’s San Diego lab for a confidential visit.
Madan, who lives in Bellevue, Wash., agreed Aug. 1 to pay about $28,000 to settle the SEC allegations.
To contact the reporter on this story: Jennifer Bennett in Washington at email@example.com
To contact the editor responsible for this story: Seth Stern at firstname.lastname@example.org
Copyright © 2018 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)